Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7344790 | 1.00 | GLA (0.55) | GLASMN1; SMN2CYP1A2MAPK1ITGB3 | |
| SCHEMBL7508214 | 0.98 | GLA (0.53) | GLASMN1; SMN2CYP1A2MAPK1ITGB3 | |
| Hydrochloric Acid SCHEMBL28282429 | 0.98 | GLA (0.59) | GLASMN1; SMN2CYP1A2MAPK1ITGB3 | |
| SCHEMBL7528972 | 0.98 | GLA (0.53) | GLASMN1; SMN2CYP1A2MAPK1ITGB3 | |
| SCHEMBL8795424 | 0.98 | GLA (0.53) | GLASMN1; SMN2CYP1A2MAPK1ITGB3 | |
| Aziridine SCHEMBL28507214 | 0.93 | GLA (0.57) | GLASMN1; SMN2CYP1A2MAPK1ITGB3 | |
| SCHEMBL3193772 | 0.89 | GLA (0.46) | GLASMN1; SMN2CYP1A2MAPK1ITGB3 | |
| SCHEMBL6371114 | 0.89 | CXCR4 (0.61) | GLASMN1; SMN2CYP1A2MAPK1ITGB3 | |
| SCHEMBL9059317 | 0.89 | CXCR4 (0.52) | GLASMN1; SMN2CYP1A2MAPK1ITGB3 | |
| SCHEMBL28386664 | 0.87 | GLA (0.44) | GLASMN1; SMN2CYP1A2MAPK1ITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119752387-A | Aldehyde-free polyurethane adhesive for high-conductivity leather products containing imidazole heterocycle ionic liquid and preparation method thereof | 广东菲安妮皮具股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-110845444-B | Dimethomorph hapten, artificial antigen and antibody, and preparation method and application thereof | 北京勤邦生物技术有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-110845444-A | Dimethomorph hapten, artificial antigen and antibody, and preparation method and application thereof | 北京勤邦生物技术有限公司 | 2020-02-28 | — | — | CN | claimed |
| EP-2455081-A1 | S1P1 receptor agonists for use in the treatment of crohn's disease | Almirall, S.A. (ES) | 2012-05-23 | — | — | EP | claimed |
| EP-2455080-A1 | S1P1 receptor agonists for use in the treatment of multiple sclerosis | Almirall, S.A. (ES) | 2012-05-23 | — | — | EP | claimed |
| US-20110311485-A1 | 1,2,4-OXADIAZOLE DERIVATIVES AND THEIR THERAPEUTIC USE | ALMIRALL S.A. (ES) | 2011-12-22 | — | — | US | claimed |
| EP-2370431-A1 | 1, 2, 4 -OXADIAZOLE DERIVATIVES AND THEIR THERAPEUTIC USE | Almirall S.A. (ES) | 2011-10-05 | — | — | EP | claimed |
| US-8017104-B2 | diagnostic contrast agent comprising a water dispersible, near-infrared tricarbocyanine, enamine-functionalized dye having a Stoke shift of greater than 50 | CARESTREAM HEALTH, INC. (US) | 2011-09-13 | — | — | US | claimed |
| WO-2010072352-A1 | 1, 2, 4 -OXADIAZOLE DERIVATIVES AND THEIR THERAPEUTIC USE | ALMIRALL S.A. (ES) | 2010-07-01 | — | — | WO | claimed |
| EP-2202232-A1 | 1,2,4-oxadiazole derivatives and their therapeutic use | Laboratorios Almirall, S.A. (ES) | 2010-06-30 | — | — | EP | claimed |
| US-20080206886-A1 | Large stoke shift dye used for optical imaging | TROPHY DENTAL INC. | 2008-08-28 | — | — | US | claimed |
| US-5614535-A | Adhesion receptor antagonists | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1997-03-25 | — | — | US | claimed |
| US-20260007787-A1 | RADIOPHARMACEUTICAL SMALL MOLECULE INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN FOR TARGETED THERAPY AND DIAGNOSTIC IMAGING OF DESMOPLASTIC TUMORS | TRUSTEES OF TUFTS COLLEGE | 2026-01-08 | — | — | US | disclosed |
| US-20250304810-A1 | INK JET INK, IMAGE RECORDING METHOD, AND MANUFACTURING METHOD OF LAMINATE | FUJIFILM CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| EP-4624539-A1 | INK JET INK, IMAGE RECORDING METHOD, AND MANUFACTURING METHOD OF LAMINATE | FUJIFILM Corporation (JP) | 2025-10-01 | — | — | EP | disclosed |
| CN-119752387-A | Aldehyde-free polyurethane adhesive for high-conductivity leather products containing imidazole heterocycle ionic liquid and preparation method thereof | 广东菲安妮皮具股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| US-4220704-A | Water soluble photosensitive resin compositions comprising a polyamide or its salt | TOYOBO CO., LTD. (JP) | 1980-09-02 | — | — | US | disclosed |
| US-4188221-A | REACTION PRODUCT OF (METH)ACRYLIC ACID AND A POLYGLYCIDYL ETHER OF A POLYOL, MOISTURE RESISTANCE | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1980-02-12 | — | — | US | disclosed |
| US-4145222-A | Water soluble photosensitive resin composition comprising a polyamide or its ammonium salt | TOYOBO CO., LTD. (JP) | 1979-03-20 | — | — | US | disclosed |
| US-3993694-A | BACTERICIDE | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110311485-A1 | 1,2,4-OXADIAZOLE DERIVATIVES AND THEIR THERAPEUTIC USE | S1PR1, S1PR2, S1PR3 | GLA 3647/4885SMN1; SMN2 1494/4885CYP1A2 1524/4885 |
| US-20260007787-A1 | RADIOPHARMACEUTICAL SMALL MOLECULE INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN FOR TARGETED THERAPY AND DIAGNOSTIC IMAGING OF DESMOPLASTIC TUMORS | FIBP, FRS2, FGFR1 | GLA 1013/4885SMN1; SMN2 4443/4885CYP1A2 4702/4885 |
| US-20080206886-A1 | Large stoke shift dye used for optical imaging | ESYT1, SLC7A5, ESYT2 | GLA 1723/4885SMN1; SMN2 951/4885CYP1A2 3935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.